Amyloid immunotherapy for early Alzheimer’s: Promising but fraught with challenges

Researchers highlighted the complexities of using amyloid immunotherapy for early Alzheimer’s disease, discussing its clinical benefits, challenges, and broader health implications. Despite some positive results, concerns over adverse effects, trial biases, and cost hinder widespread adoption.

Diabetes in Night Owls; ‘Paradigm-Shifting’ Drugs; Transgender Trials Unethical?

Compared with women who are early birds, night owls had a 19% higher risk of developing diabetes, after taking into account lifestyle and sociodemographic factors.

September 20, 2023

Neuroscientists link visual perception shifts to walking rhythm

For the first time, neuroscientists have established a link between shifts in our visual perception and the cadence of our steps while walking.

March 7, 2024

Antibiotic Overuse in Preemies’ Early Life Tied to Higher Risk of BPD, Death

Overuse of antibiotics early in life may increase the risk for bronchopulmonary dysplasia (BPD) or mortality in very premature infants, a national cohort study from

June 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.